
Deallus
Strategic intelligence consultancy minimizing risk and maximizing value in the global life sciences sector.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
* | N/A | Acquisition | |
Total Funding | 000k |
GBP | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 43 % | (22 %) | (24 %) | 4 % | 29 % | 18 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (12 %) | 9 % | 14 % | 3 % | 4 % | 8 % | 2 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (8 %) | 7 % | 10 % | 1 % | 2 % | 6 % | 1 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Deallus is a global consultancy specializing in strategic intelligence within the life sciences sector. The company focuses on providing competitive intelligence to help clients navigate the complex landscape of healthcare advancements. Deallus serves a diverse range of clients, including pharmaceutical companies and healthcare organizations, by offering insights into market access strategies, competitive landscapes, and stakeholder analysis. Operating on a global scale, Deallus assists clients in minimizing risks and maximizing value through tailored strategic roadmaps. The business model revolves around delivering in-depth analysis and actionable strategies that empower clients to make informed decisions. Deallus is committed to corporate social responsibility, aiming to exemplify sustainable business practices and foster an empowering work environment. Keywords: life sciences, consultancy, competitive intelligence, healthcare, strategy, market access, risk management, stakeholder analysis, global, sustainability.